Core Insights - GUANZE MEDICAL reported a total revenue of approximately RMB 31.855 million for the six months ending June 30, 2025, representing a year-on-year decrease of 20.42% primarily due to a decline in sales of medical imaging film products [1] - The gross profit for the period was RMB 13.383 million, down 38.83% compared to the previous year [1] - The company recorded a profit attributable to owners of RMB 3.368 million, contrasting with a loss of RMB 0.16 million in the same period last year, resulting in a basic earnings per share of RMB 0.003 [1] - The gross margin decreased by approximately 12.7 percentage points to about 42.0%, mainly due to a decline in the average selling price of medical imaging film products [1]